Jul 21, 2017 22:45 pm UTC| Business
NEW YORK, July 21, 2017 -- Stull, Stull Brody ("SSB") announces that a class action lawsuit was commenced in the United States District Court for the Southern District of Ohio on behalf of purchasers of Teva...
Veterinary Wellness Center of Boerum Hill Announces Special on its Basic Vaccine Package
Jul 21, 2017 22:39 pm UTC| Business
BROOKLYN, N.Y., July 21, 2017 -- Veterinary Wellness Center of Boerum Hill announced a special on its Basic Vaccine Package. This package covers all of the core vaccines for dogs or cats, plus a pest prevention...
Coca-Cola Bottling Co. Consolidated Announces Third Quarter Dividend
Jul 21, 2017 22:12 pm UTC| Business
CHARLOTTE, N.C., July 21, 2017 -- Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) announced that the Board of Directors has declared a dividend for the third quarter of 2017 of $.25 per share on shares of the...
Eye Care Specialists of Florida Announces Blepharitis Treatment
Jul 21, 2017 22:06 pm UTC| Business
KISSIMMEE, Fla., July 21, 2017 -- Eye Care Specialists of Florida released information on a treatment for dry eye and blepharitis, BlephEx. This treatment is done in the eye doctor's office to prevent, reduce, or...
Speedway Motorsports, Inc. Schedules 2017 Second Quarter Earnings Conference Call
Jul 21, 2017 22:00 pm UTC| Business
CONCORD, N.C., July 21, 2017 -- Speedway Motorsports, Inc. (NYSE:TRK), a leading marketer, promoter and sponsor of motorsports entertainment, will host its quarterly conference call on Wednesday, July 26, 2017 at 10:00...
We Serve Those Who Protect and Serve us
Jul 21, 2017 21:47 pm UTC| Business
WALDWICK, N.J., July 21, 2017 -- Waldwick physical therapy and chiropractic care experts, Total Health Associates, would like to emphasize the importance of a personalized recovery plan for anyone who has been injured. ...
Ultragenyx to Host Conference Call for Second Quarter 2017 Financial Results and Corporate Update
Jul 21, 2017 21:41 pm UTC| Business
NOVATO, Calif., July 21, 2017 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that it will host...